Life Sciences Tools and Services
Company Overview of Trino Therapeutics Ltd.
Trino Therapeutics Ltd., a drug discovery and early drug development company, focuses on anti-inflammatory therapeutics. It develops drug candidates from drugs based on indane dimers derived from a Taiwanese fern. The company’s lead candidate is a potential drug for the treatment of inflammatory bowel disease, which could be used in ulcerative colitis and Crohn’s disease. Its drugs also offer candidates for applications in dermatology, pulmonary, and auto-immune diseases. Trino Therapeutics Ltd. was formerly known as Pharmatrin Ltd. The company was founded in 1999 and is based in Dublin, Ireland.
Trinity Technology and Enterprise Campus
Founded in 1999
353 1 670 9865
Key Executives for Trino Therapeutics Ltd.
Trino Therapeutics Ltd. Key Developments
Similar Private Companies By Industry
|Clinical Conduct Associates, Ltd.||Europe|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
The information and data displayed in this profile are created and managed by Capital IQ, a Standard & Poor's company. Bloomberg.com does not create or control the content. For inquiries, please contact Capital IQ directly by clicking here.
Most Searched Private Companies
|Company Name||Geographic Region|
|Lawyers Committee for Civil Rights Under Law||United States|
|NYC2012, Inc.||United States|
|Rush University||United States|
|Citizens Budget Commission||United States|
Sponsored Financial Commentaries
Only a company representative may request an update for the company profile. Documentation will be required.
To contact Trino Therapeutics Ltd., please visit www.trinotherapeutics.com. Company data is provided by Capital IQ. Please use this form to report any data issues.